title: Dose escalation of cisplatin (P), etoposide (E), and ifosfamide (I) with GM-CSF for advanced germ cell tumors.
authors.affiliation: Division of Hematology, Hannover University Medical School, Germany.
authors.forename: H J
authors.initials: HJ
authors.lastname: Schmoll
authors.forename: C
authors.initials: C
authors.lastname: Bokemeyer
authors.forename: A
authors.initials: A
authors.lastname: Harstrick
authors.forename: H J
authors.initials: HJ
authors.lastname: Illiger
authors.forename: B
authors.initials: B
authors.lastname: Metzner
authors.forename: U
authors.initials: U
authors.lastname: Ruther
authors.forename: A
authors.initials: A
authors.lastname: Osternamm
authors.forename: J
authors.initials: J
authors.lastname: Preiss
authors.forename: H
authors.initials: H
authors.lastname: Wilke
authors.forename: J
authors.initials: J
authors.lastname: Hohnloser
mesh_terms: D002945:Cisplatin / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005047:Etoposide / Q000008:administration & dosage / Q000627:therapeutic use*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D005047:Etoposide; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D002945:Cisplatin; D007069:Ifosfamide